Bioequivalence Studies

Micro Therapeutic Research Labs (MTRL) is a trusted leader in conducting bioequivalence studies in compliance with international regulatory requirements. With over 1,700 successfully completed BA/BE studies, MTRL has built a strong reputation for accuracy, quality, and reliability.

01Bioequivalence Studies

Bioequivalence Studies

Our independent quality assurance department ensures every study meets stringent global standards, including US FDA, EMA, ANVISA, and NPRA guidelines.

Backed by a diverse volunteer database of more than 32,000 participants, we specialize in healthy volunteers, special populations, and female volunteers. Our expert volunteer mobilization team guarantees timely study execution, making MTRL a preferred partner for global clinical research.

MTRL can undertake the following studies:

Single & multiple dose studies.
Fasting & Fed condition studies.
Drug-Drug Interaction (DDI).
Pharmacokinetic interaction studies.
Pharmacodynamic Studies.
Food Effect studies.
Cross over, parallel, partial and fully replicate studies.
Proof of concept studies.
Special population studies (postmenopausal & adult female studies and geriatric studies).
Studies comparing routes of administration.
Studies comparing immediate and modified release forms.

Capability for Various Delivery Routes & Formulations:

Oral Dosage Forms: Tablets and Capsules; Suspensions; Buccal, Sublingual, and Lozenges
Injectables: IV, IM, SC
Inhalers
Transdermal Patches
Nasal Sprays
Suppositories
Ointments & Creams

Fig. 02Oral solid dosage · capsule

Why Choose Micro Therapeutic Research Labs?

Bioequivalence, run end to end

Features

1,700+ Studies
Every Delivery Route
Study Designs
Regulatory Compliance

Track record

1,700⁺BA/BE studies completed

32,000+Volunteer database

QAIndependent department

Advanced bio-analytical testing

Over 1,700 completed BA/BE studies, a volunteer database of more than 32,000 participants, and dedicated state-of-the-art facilities for highly accurate, reproducible sample analysis across all trials.

Delivery routes

POTablets & CapsulesOral solid dosage
POSuspensionsOral liquid
SLBuccal, Sublingual, LozengesOromucosal
INJInjectablesIV, IM, SC
INHInhalersPulmonary
TDTransdermal PatchesSkin
INNasal SpraysIntranasal
PRSuppositoriesRectal
TOPOintments & CreamsTopical

Capability for every formulation

From oral solids to injectables, inhalers, patches and topicals, including studies comparing routes of administration and immediate against modified release forms.

Single & multiple dosePK
Fasting & fed conditionFood
Food effect studiesFood
Drug-drug interactionDDI

Every study design, one site

Single and multiple dose, fasting and fed, crossover, parallel and replicate designs, PK interaction and pharmacodynamic studies, and special population studies.

Audits cleared

US FDA
EMA
ANVISA
NPRA

Highest regulatory compliance

Successfully cleared audits by US FDA, EMA, ANVISA, and NPRA ensure unparalleled data integrity and acceptance. Dedicated teams offer round-the-clock responsiveness to keep every project moving.

Explore

More from MTRL

See all

01

Bioequivalence Studies